China Clinical Trial Management Services Market Size & Outlook

The clinical trial management services market in China is expected to reach a projected revenue of US$ 3,028.5 million by 2030. A compound annual growth rate of 8.9% is expected of China clinical trial management services market from 2024 to 2030.
Revenue, 2023 (US$M)
$1,667.3
Forecast, 2030 (US$M)
$3,028.5
CAGR, 2024 - 2030
8.9%
Report Coverage
China

China clinical trial management services market, 2018-2030 (US$M)

China

China clinical trial management services market highlights

  • The China clinical trial management services market generated a revenue of USD 1,667.3 million in 2023 and is expected to reach USD 3,028.5 million by 2030.
  • The China market is expected to grow at a CAGR of 8.9% from 2024 to 2030.
  • In terms of segment, site management & monitoring was the largest revenue generating services in 2023.
  • Medical Writing is the most lucrative services segment registering the fastest growth during the forecast period.


Clinical trial management services market data book summary

Market revenue in 2023USD 1,667.3 million
Market revenue in 2030USD 3,028.5 million
Growth rate8.9% (CAGR from 2023 to 2030)
Largest segmentSite management & monitoring
Fastest growing segmentMedical Writing
Historical data2018 - 2022
Base year2023
Forecast period2024 - 2030
Quantitative unitsRevenue in USD million
Market segmentationClinical Trial Monitoring, Regulatory Submissions, Clinical Trial Data Management, Medical Writing, Site management & monitoring
Key market players worldwideCharles River Laboratories International Inc, Medpace Holdings Inc, Wuxi AppTec Co Ltd, SGS AG, Labcorp Holdings Inc, IQVIA Holdings Inc, Syneos Health, Icon PLC, CTI Clinical Trial and Consulting Services, Atlantic Research Group


Other key industry trends

  • In terms of revenue, China accounted for 5.3% of the global clinical trial management services market in 2023.
  • Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
  • In Asia Pacific, Japan clinical trial management services market is projected to lead the regional market in terms of revenue in 2030.
  • India is the fastest growing regional market in Asia Pacific and is projected to reach USD 1,979.2 million by 2030.

No credit card required*

Horizon in a snapshot

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more

Clinical Trial Management Services Market Companies

Name Profile # Employees HQ Website

China clinical trial management services market outlook

The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to clinical trial management services market will help companies and investors design strategic landscapes.


Site management & monitoring was the largest segment with a revenue share of 33.97% in 2023. Horizon Databook has segmented the China clinical trial management services market based on clinical trial monitoring, regulatory submissions, clinical trial data management, medical writing, site management & monitoring covering the revenue growth of each sub-segment from 2018 to 2030.


Reasons to subscribe to China clinical trial management services market databook:

  • Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
  • Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
  • Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
  • Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
  • Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.

Target buyers of China clinical trial management services market databook

  • Our clientele includes a mix of clinical trial management services market companies, investment firms, advisory firms & academic institutions.
  • 30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
  • Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
  • The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.

Horizon Databook provides a detailed overview of country-level data and insights on the China clinical trial management services market, including forecasts for subscribers. This country databook contains high-level insights into China clinical trial management services market from 2018 to 2030, including revenue numbers, major trends, and company profiles.

Partial client list

  • logo

China clinical trial management services market report size, by services, 2018-2030 (US$M)

China Clinical Trial Management Services Market Share, 2023 & 2030 (US$M)

China clinical trial management services market report size, by services, 2018-2030 (US$M)

Sign up - it's easy, and free!

Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our free plan indefinitely.

Explore all plans

Included in Horizon account

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more